Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I AGREE-$$$$$$$$$$$$$$$$$$$$$$
Halberd Designated "Pink Current Information" by OTC and Continues Technology Progress
Press Release | 06/15/2020
Halberd Designated "Pink Current Information" by OTC and Continues Technology Progress
JACKSON CENTER, PA / ACCESSWIRE / June 15, 2020 / Halberd Corporation (OTC PINK:HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information."
William A. Hartman, newly appointed Chairman, President and CEO explains, "Now that Halberd has been designated by OTC Markets as current in its filings and is now current with the Colorado Secretary of State, this completes the first steps in a reorganization to assure a smooth transition from a holding company to a fully reporting entity."
Mr. Hartman continued, "In exchange for royalties to be paid, Halberd Corporation has acquired the exclusive rights to two granted patents related to extracorporeal treatment of disease as well as three provisional patent applications designed to treat coronavirus, extracorporeally. Upon consummation of pending financial arrangements, we plan to begin research in the 3rd quarter at a major university partner, which is experienced in the creation of antibodies. The purpose of this research is to develop appropriate molecules for targeting the coronavirus disease antigens. As indicated in our prior press release of June 9, 2020, Dr. Patricio Reyes' will be heading up our Scientific Advisory Board to guide this work."
"Our efforts will be focused on developing the technology represented in our licensed intellectual property: U.S. Patent 9,216,386 and U.S. Patent 8,758,287; and three provisional patent applications:
"Method for Treating and Curing Covid-19 Infection"
"Method for Treating COVID-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in COVID-19 Patients", and
"Method for Treating and Curing COVID-19 Infection by Utilizing a Laser to Eradicate the Virus".
Hartman continued, "The most exciting of these is the Laser Eradication approach. It is the novel solution of first mapping antigens and cytokines, then tagging/targeting them for eradication with a Nano Laser technology (Map & ZapTM) being developed in conjunction with team member and scientist, Mohammed Zulfiquar, CEO of Datatecnics, a privately held company in the UK.
"Another outstanding feature of Halberd Corporation's approach is that it is designed to be remedial as well as treatment which can be adapted to address virus mutations," Hartman concluded.
For more information please contact:
Halberd Corporation
William A. Hartman
w.hartman@halberdcorporation.com;
https://www.halberdcorporation.com
Twitter: @HalberdC
About Halberd Corporation
Halberd Corporation (OTC-PINK: "HALB") is a publicly traded company on the OTC Market and intends to become a fully reporting entity. It is pursuing efforts to vanquish COVID-19 and holds the exclusive rights to U.S. Patent 9,216,386 and U.S. Patent 8,758,287 for the extracorporeal treatment technology and the exclusive rights to three provisional patents: "Method for Treating and Curing Covid-19 Infection;" "Method for Treating COVID-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in COVID-19 Patients" and "Method for Treating and Curing COVID-19 Infection by Utilizing a Laser to Eradicate the Virus".
About Datatecnics Corp., Ltd.
Datatecnics is a privately held UK-based company, established in 2011. The founder and holder of over one hundred patents, Mohammed Zulfiquar, invented CIPPS (Critical Infrastructure Pipeline Protection System) technology, co-owned by United Utilities, that converts dumb metal surfaces into intelligent self-reporting infrastructure which can communicate big data via M2M (Machine to Machine) or to central control systems, currently with 33 operational installations. The company is a leader in printed sensors and nano science.
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.
Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives -
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.
The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment or other strategies with regard to COVID-19.
The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.
We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be adverse to the pecuniary interests of the Company and of its shareholders.
SOURCE: Halberd Corporation
View source version on accesswire.com:
https://www.accesswire.com/593873/Halberd-Designated-Pink-Current-Information-by-OTC-and-Continues-Technology-Progress
Tradestation
Sponsored By: Tradestation
Trade Commission-Free* Stocks, ETFs, Options, and Futures with The Award-Winning Technology of TradeStation. Read More
Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filing
link please
heres to looking up,$$$$$$$$$$$$$$$$$$$$$$4
u bet it is,$$$$$$$$$$$$$$$$$
STNT_read pages 33 and 34,about the big deal
STNT,in there fins-Pursuant to the terms of the Agreement, the Company received all of the stock and other ownership of New Earth
Development Corporation, which makes both New Earth Development Corporation and its wholly owned subsidiary,
Hemp Armor Inc, wholly owned subsidiaries of the Company as of February 21, 2020. As consideration for all of the
stock and ownership interests in New Earth Development Corporation, the Company has agreed to (i) issue 2,500,000
shares of its common stock in exchange for all of the shares and ownership interests of New Earth Development
Corporation, (ii) provide five million dollars USD ($5,000,000) of funding to New Earth Development Corporation
(the “Funding”), and (iii) agrees that Joshua Spooner shall serve as the Chief Executive Officer of Hemp Armor Inc.,
with Mr. Spooner managing Hemp Armor Inc. from his Illinois office.
HUGE MONEY HERE,DONT MISS the boat=https://www.otcmarkets.com/stock/HALB/news/Halberd-Corp-Announces-CorrectionClarification-to-Eliminate-Name-Confusion?id=264016
is the increase in the OS still on,thank u
LOOKS LIKE ITS UP TO ME<6x6.50$$$$$$$$$$$$$$$$$$$$
when r the fins coming out anybody know,?
10-K=https://ih.advfn.com/stock-market/USOTC/premier-biomedical-pk-BIEI/stock-news/82474110/annual-report-10-k
biei-8k=Exhibit 10.1
TECHNOLOGY ACQUISITION AND FINANCING AGREEMENT
This Technology Acquisition and Financing Agreement (this “Agreement”) is entered into on May 12, 2020 (the “Effective Date”) for the collective acquisition, development, financing, implementation and commercialization of certain technologies that may be a potential treatment for the COVID-19 virus and its effects on the human body (collectively referred to herein as the “Joint Venture”) by and between:
Premier Biomedical, Inc. (OTC Pink: BIEI), a Nevada corporation (“Premier”),
Technology Health, Inc. (OTC Pink: HALB), a Colorado corporation f/k/a Halberd Corporation (“THI”),
RushNet Inc. (OTC Pink: RSHN), a Colorado corporation (“RushNet”), and
Gold River Productions, Inc., formerly XYZ Hemp, Inc. (OTC Pink: GRPS) a Colorado corporation (“Gold River”).
Each shall be referred to as a “Party” and collectively as the “Parties.”
RECITALS:
Exhibit 10.1
TECHNOLOGY ACQUISITION AND FINANCING AGREEMENT
This Technology Acquisition and Financing Agreement (this “Agreement”) is entered into on May 12, 2020 (the “Effective Date”) for the collective acquisition, development, financing, implementation and commercialization of certain technologies that may be a potential treatment for the COVID-19 virus and its effects on the human body (collectively referred to herein as the “Joint Venture”) by and between:
Premier Biomedical, Inc. (OTC Pink: BIEI), a Nevada corporation (“Premier”),
Technology Health, Inc. (OTC Pink: HALB), a Colorado corporation f/k/a Halberd Corporation (“THI”),
RushNet Inc. (OTC Pink: RSHN), a Colorado corporation (“RushNet”), and
Gold River Productions, Inc., formerly XYZ Hemp, Inc. (OTC Pink: GRPS) a Colorado corporation (“Gold River”).
Each shall be referred to as a “Party” and collectively as the “Parties.”
On May 12, 2020, we assigned our rights in these two patents to Technology Health, Inc. pursuant to an Intellectual Property Agreement in hopes that they will be able to finance and develop the technologies. The assignment is part of an agreement with Technology Health, Inc., and two other companies to pursue a novel coronavirus extracorporeal treatment which combines our antigen mapping technique with Datatecnics’ laser ablation technology in a focused “Map and ZapTM” treatment protocol disclosed in a provisional patent application that is intended to eliminate COVID-19 antigens and potential mutations. Research is expected to start in the second quarter of 2020 to develop complexing agents to bind with coronavirus antigens which can be illuminated and eliminated using a computer-controlled targeting and laser system. The proposed hospital/clinic process would illuminate the compounded molecular target disease antigens for destruction by a nano-focus laser, and the purified blood would then be returned to the patient.
Section 9 – Financial Statements and Exhibits.
is that more sells then buys,thanku
Negotiations are in-process with two funding sources as part of our overall strategy to recapitalize the company and to eliminate all toxic debt on Premier Biomedical's balance sheet."
Premier Biomedical Rescinds Previously Planned Increase in Authorized Shares
Press Release | 05/05/2020
JACKSON CENTER, PA / ACCESSWIRE / May 5, 2020 / Premier Biomedical, Inc. (OTC PINK:BIEI) President and CEO, William A. Hartman stated, "As a follow up to our press release dated April 6, 2020, Premier Biomedical has decided not to increase our authorized shares at this time as it is not in the best interests of our shareholders. Premier Biomedical previously announced that we had cancelled a reverse split, so it made sense not to go ahead with the increase in authorized shares while we await either non-convertible or fixed-price convertible preferred funding. Negotiations are in-process with two funding sources as part of our overall strategy to recapitalize the company and to eliminate all toxic debt on Premier Biomedical's balance sheet."
Hartman continued, "Premier Biomedical has outstanding intellectual properties, but we believe that we have been held back by toxic debt. We are resolved to correct that problem immediately. We anticipate having an update on further major corporate developments in the very near future."
For more information please contact:
William A. Hartman
President and CEO
got me some more,before the big BANG
told u all note holder is threw,moving on up,$$$$$$$$$$$$$$$$$$$$$4
10 mil shares come in to play,a note holder looks like its about over on his sellind,should go up from here$$$$$$$$$$$$$$$$$$$$$
chk all these 4s out=https://www.otcmarkets.com/stock/BIEI/disclosure
otc as of 03-16-2020=os=484 mil